      1 conformity
      3 liberia
      1 46year
      9 release
<<CONTENT>>
building giant in asbestos payout

australian building products group james hardie has agreed to pay 11bn 568m to victims of asbestosrelated diseases

the landmark deal could see thousands of people suffering from lung diseases  caused by asbestos the company once made  receive compensation the move follows angry protests after the firm said a previous compensation fund was running out of money a subsequent new south wales state inquiry criticised hardies actions in september the inquiry found that the company had misled the public about the amount of money set aside to cover its asbestosrelated liabilities sparking the resignation of its then chief executive peter macdonald

campaigners welcomed news of the preliminary agreement this is a momentous day in the fight for victims and their families said asbestosis sufferer bernie banton who leads a victims association there is still a long way to go but we are getting there james hardie chairwoman meredith hellicar said the deal provided for a funding arrangement that is affordable sensible researchers and workable at the end of the day we are dealing with compensation for people who are terminally ill we dont know exactly how many of them there will be we dont know over what exact period they will fall ill she said however the deal still has to receive the approval of hardies shareholders

hardie which currently makes more than 80% of its revenues in the us was once australias biggest supplier of asbestos building materials in 2001 the company set up a fund to compensate asbestos victims but it later admitted the fund was running short of money a decision by hardie to move its headquarters to the netherlands  while remaining a listed company in australia  provoked a damaging public outcry victims groups accusing it of trying to escape its responsibilities by moving abroad a charge the company denies australias securities watchdog is currently investigating hardies former chief executive and former chief financial officer over allegations of misleading measuring investors and the general public
 sars